68 related articles for article (PubMed ID: 7945272)
21. Partial maturation and light chain restriction of Abelson virus-transformed B cell precursors.
Boss MA; Greaves MF; Teich N
Eur J Immunol; 1981 Feb; 11(2):136-40. PubMed ID: 6783433
[TBL] [Abstract][Full Text] [Related]
22. Activation of p65 NF-kappaB protein by p210BCR-ABL in a myeloid cell line (P210BCR-ABL activates p65 NF-kappaB).
Hamdane M; David-Cordonnier MH; D'Halluin JC
Oncogene; 1997 Nov; 15(19):2267-75. PubMed ID: 9393872
[TBL] [Abstract][Full Text] [Related]
23. Bone marrow microenvironmental changes in aged mice compromise V(D)J recombinase activity and B cell generation.
Labrie JE; Borghesi L; Gerstein RM
Semin Immunol; 2005 Oct; 17(5):347-55. PubMed ID: 15963731
[TBL] [Abstract][Full Text] [Related]
24. Bcr-Abl has a greater intrinsic capacity than v-Abl to induce the neoplastic expansion of myeloid cells.
Gross AW; Ren R
Oncogene; 2000 Dec; 19(54):6286-96. PubMed ID: 11175343
[TBL] [Abstract][Full Text] [Related]
25. The v-abl tyrosine kinase negatively regulates NF-kappa B/Rel factors and blocks kappa gene transcription in pre-B lymphocytes.
Klug CA; Gerety SJ; Shah PC; Chen YY; Rice NR; Rosenberg N; Singh H
Genes Dev; 1994 Mar; 8(6):678-87. PubMed ID: 7926758
[TBL] [Abstract][Full Text] [Related]
26. PKC eta directs induction of IRF-4 expression and Ig kappa gene rearrangement in pre-BCR signaling pathway.
Oda A; Ono T; Yamamoto M; Goitsuka R; Kitamura D
Int Immunol; 2008 Nov; 20(11):1417-26. PubMed ID: 18780722
[TBL] [Abstract][Full Text] [Related]
27. Maturation of B cell precursors is impaired in thymic-deprived nude and old mice.
Szabo P; Zhao K; Kirman I; Le Maoult J; Dyall R; Cruikshank W; Weksler ME
J Immunol; 1998 Sep; 161(5):2248-53. PubMed ID: 9725218
[TBL] [Abstract][Full Text] [Related]
28. Transforming pathways activated by the v-Abl tyrosine kinase.
Shore SK; Tantravahi RV; Reddy EP
Oncogene; 2002 Dec; 21(56):8568-76. PubMed ID: 12476303
[TBL] [Abstract][Full Text] [Related]
29. Structure and function of the Abelson murine leukemia virus transforming gene.
Wang JY; Prywes R; Baltimore D
Prog Clin Biol Res; 1983; 119():57-63. PubMed ID: 6306691
[TBL] [Abstract][Full Text] [Related]
30. B lineage-restricted rearrangement of a human Ig kappa transgene.
Cavelier P; Nato F; Coquilleau I; Rolink A; Rougeon F; Goodhardt M
Eur J Immunol; 1997 Jul; 27(7):1626-31. PubMed ID: 9247570
[TBL] [Abstract][Full Text] [Related]
31. Nonrandom cytogenetic changes accompany malignant progression in clonal lines abelson virus-infected lymphocytes.
Clark SS; Liang Y; Reedstrom CK; Wu SQ
Blood; 1994 Dec; 84(12):4301-9. PubMed ID: 7994046
[TBL] [Abstract][Full Text] [Related]
32. NF-kappaB1 can inhibit v-Abl-induced lymphoid transformation by functioning as a negative regulator of cyclin D1 expression.
Nakamura Y; Grumont RJ; Gerondakis S
Mol Cell Biol; 2002 Aug; 22(15):5563-74. PubMed ID: 12101248
[TBL] [Abstract][Full Text] [Related]
33. Lymphoid cells transformed by Abelson virus require the v-abl protein-tyrosine kinase only during early G1.
Chen YY; Rosenberg N
Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6683-7. PubMed ID: 1379715
[TBL] [Abstract][Full Text] [Related]
34. The extreme carboxyl terminus of v-Abl is required for lymphoid cell transformation by Abelson virus.
Warren D; Griffin DS; Mainville C; Rosenberg N
J Virol; 2003 Apr; 77(8):4617-25. PubMed ID: 12663768
[TBL] [Abstract][Full Text] [Related]
35. Hyperexpression of interleukin-7 is not necessary or sufficient for transformation of a pre-B lymphoid cell line.
Young JC; Gishizky ML; Witte ON
Mol Cell Biol; 1991 Feb; 11(2):854-63. PubMed ID: 1990288
[TBL] [Abstract][Full Text] [Related]
36. Differentiation of an Abelson virus-transformed immature B precursor cell line under the expression of tyrosine kinase activity of v-abl oncogene product.
Maeda T; Owada MK; Sugiyama H; Miyake S; Tani Y; Ogawa H; Oka Y; Komori T; Soma T; Kishimoto S
Cell Differ; 1987 Apr; 20(4):263-9. PubMed ID: 2438051
[TBL] [Abstract][Full Text] [Related]
37. Pre-B-cells transformed by ts Abelson virus rearrange kappa and lambda [correction of gamma] genes in early G1.
Wang LC; Chen YY; Rosenberg N
Curr Top Microbiol Immunol; 1995; 194():355-61. PubMed ID: 7895509
[No Abstract] [Full Text] [Related]
38. Chronic myeloproliferative disease induced by site-specific integration of Abelson murine leukemia virus-infected hemopoietic stem cells.
Han XD; Wong PM; Chung SW
Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10129-33. PubMed ID: 1682923
[TBL] [Abstract][Full Text] [Related]
39. Mutation of Tp53 contributes to the malignant phenotype of Abelson virus-transformed lymphoid cells.
Thome KC; Radfar A; Rosenberg N
J Virol; 1997 Nov; 71(11):8149-56. PubMed ID: 9343165
[TBL] [Abstract][Full Text] [Related]
40. Oncogenic v-Abl tyrosine kinase can inhibit or stimulate growth, depending on the cell context.
Renshaw MW; Kipreos ET; Albrecht MR; Wang JY
EMBO J; 1992 Nov; 11(11):3941-51. PubMed ID: 1396587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
